Literature DB >> 2934041

Teratogenesis and reproductive safety evaluation of the retinoid etretin (Ro 10-1670).

A Kistler, H Hummler.   

Abstract

Reproduction and teratology studies were performed with etretin, the free acid analog of the retinoid etretinate. The lowest teratogenic dose of etretin in mice, rats and rabbits was 3, 15 and 0.6 mg/kg, respectively. In all three species, the lowest dose which was embryolethal, fetolethal or reduced the survivability of the pups during lactation was 2-3 times higher than the above doses. In rats, the lowest effective dose of etretin was 3 mg/kg in both the study for fertility and general reproductive performance and the peri- and postnatal study. The main adverse effect in these two experiments was a reduced survival of the F1-generation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2934041     DOI: 10.1007/BF00292617

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  11 in total

1.  Limb development in mouse embryos. I. Analysis of teratogenic effects of retinoic acid.

Authors:  D M Kochhar
Journal:  Teratology       Date:  1973-06

2.  Vitamin A and retinoids: from nutrition to pharmacotherapy in dermatology and oncology.

Authors:  W Bollag
Journal:  Lancet       Date:  1983-04-16       Impact factor: 79.321

3.  Teratogenicity of isotretinoin.

Authors:  F W Rosa
Journal:  Lancet       Date:  1983-08-27       Impact factor: 79.321

4.  A test procedure based on ranks for the statistical evaluation of toxicological studies.

Authors:  E Lüdin
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

5.  Teratogenesis of retinoic acid in rats: susceptible stages and suppression of retinoic acid-induced limb malformations by cycloheximide.

Authors:  A Kistler
Journal:  Teratology       Date:  1981-02

Review 6.  Isotretinoin and pregnancy.

Authors:  R S Stern; F Rosa; C Baum
Journal:  J Am Acad Dermatol       Date:  1984-05       Impact factor: 11.527

7.  Oxygen consumption and survival prediction in neonatal rats exposed to prenatal hypervitaminosis A.

Authors:  L M Newman; E M Johnson; A S Cadogan
Journal:  Teratology       Date:  1983-10

8.  Introduction of late gestational teratogenesis in rat lung by hypervitaminosis A.

Authors:  L M Matthews; E M Johnson; L M Newman
Journal:  Teratology       Date:  1981-04

Review 9.  Hypervitaminosis A induced teratogenesis.

Authors:  J A Geelen
Journal:  CRC Crit Rev Toxicol       Date:  1979-11

10.  Intralitter variation of neonatal rat lung morphology following prenatal maternal hypervitaminosis A.

Authors:  L M Newman; E M Johnson; A S Cadogan
Journal:  Anat Rec       Date:  1982-10
View more
  7 in total

1.  Limb bud cell cultures for estimating the teratogenic potential of compounds. Validation of the test system with retinoids.

Authors:  A Kistler
Journal:  Arch Toxicol       Date:  1987-08       Impact factor: 5.153

Review 2.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

3.  A test procedure based on ranks for the statistical evaluation of toxicological studies.

Authors:  E Lüdin
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

4.  The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.

Authors:  G Tzimas; H Bürgin; M D Collins; H Hummler; H Nau
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

5.  Comparative teratogenicity of nine retinoids in the rat.

Authors:  J A Turton; G B Willars; J N Haselden; S J Ward; C E Steele; R M Hicks
Journal:  Int J Exp Pathol       Date:  1992-10       Impact factor: 1.925

6.  Acitretin : A Review of its Pharmacology and Therapeutic Use.

Authors:  Tania Pilkington; Rex N Brogden
Journal:  Drugs       Date:  1992-04       Impact factor: 9.546

7.  Species differences in pharmacokinetics and drug teratogenesis.

Authors:  H Nau
Journal:  Environ Health Perspect       Date:  1986-12       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.